Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Gastroenterology > Gastroenterology Hyperbilirrubinemia Precision Panel

Hyperbilirubinemia

The Igenomix Hyperbilirubinemia Precision Panel can be used to make a directed and accurate differential diagnosis of jaundice, ultimately leading to a better management and prognosis of the disease.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • The Igenomix Hyperbilirubinemia Precision Panel can be used to make a directed and accurate differential diagnosis of jaundice, ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

  • Hyperbilirubinemia is known as high amounts plasma bilirubin levels, causing a yellow discoloration of the skin, sclera, mucous membranes, and other less visible tissues in the newborn. 

  • High levels of bilirubin can deposit and accumulate ultimately resulting in neurotoxicity. It can be physiologic or pathologic. There are two types of hyperbilirubinemia depending on the chemical structure of bilirubin: conjugated and unconjugated hyperbilirubinemia. Pathologic congenital causes of hyperbilirubinemia are: Crigler-Najjar syndrome type 1 and 2, Gilbert syndrome, Dubin-Johnson syndrome, and Rotor syndrome. These diseases are inherited mainly in an autosomal recessive pattern.   

Indication

The Igenomix Hyperbilirubinemia Precision Panel is indicated for those patients with a clinical suspicion or diagnosis presenting with the following manifestations: 

  • Abdominal distention  
  • Delayed passage of meconium  
  • Light-colored stools  
  • Dark urine  
  • Infections  
  • Birth trauma  

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team for early phototherapy intervention, pharmacologic or even surgical care.  
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

Methodology

References

See scientific referrals

Rets, A., Clayton, A. L., Christensen, R. D., & Agarwal, A. M. (2019). Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia. International journal of laboratory hematology, 41 Suppl 1, 95–101. https://doi.org/10.1111/ijlh.13014 

Watchko J. F. (2013). Genetics and pediatric unconjugated hyperbilirubinemia. The Journal of pediatrics, 162(6), 1092–1094. https://doi.org/10.1016/j.jpeds.2013.01.044 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information